{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:38:56Z","timestamp":1793421536480,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","aaojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ophtha.2024.06.011","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:25:21Z","timestamp":1718299521000},"page":"1457-1467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0370-5968","authenticated-orcid":false,"given":"Marko M.","family":"Popovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5948-0331","authenticated-orcid":false,"given":"Michael","family":"Balas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SriniVas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3404-5376","authenticated-orcid":false,"given":"Ryan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie J.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audina","family":"Berrocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-3516","authenticated-orcid":false,"given":"Chui Ming","family":"Gemmy Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunir","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane J.","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-045X","authenticated-orcid":false,"given":"Peter K.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-6428","authenticated-orcid":false,"given":"Timothy Y.Y.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5911-6671","authenticated-orcid":false,"given":"Susanna S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0615-628X","authenticated-orcid":false,"given":"Yannis M.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3292-9581","authenticated-orcid":false,"given":"Giuseppe","family":"Querques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Rachitskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6114-6220","authenticated-orcid":false,"given":"Paisan","family":"Ruamviboonsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-6313","authenticated-orcid":false,"given":"Shohista","family":"Saidkasimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-7159","authenticated-orcid":false,"given":"Maria Teresa","family":"Sandinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8734-3089","authenticated-orcid":false,"given":"David H.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-1922","authenticated-orcid":false,"given":"Christina Y.","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7257-026X","authenticated-orcid":false,"suffix":"Jr.","given":"Basil K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-7058","authenticated-orcid":false,"given":"Lihteh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-6472","authenticated-orcid":false,"given":"Rajeev H.","family":"Muni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2024.06.011_bib1","first-page":"627674","article-title":"Anti-VEGF therapy and the retina: an update","author":"Tah","year":"2015","journal-title":"J Ophthalmol"},{"issue":"9583","key":"10.1016\/j.ophtha.2024.06.011_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(07)61104-0","article-title":"Clinical update: new treatments for age-related macular degeneration","volume":"370","author":"Wong","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2024.06.011_bib3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A\u00a0review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"22","key":"10.1016\/j.ophtha.2024.06.011_bib4","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMcp1003934","article-title":"Retinal-vein occlusion","volume":"363","author":"Wong","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ophtha.2024.06.011_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.ophtha.2024.06.011_bib6","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/eye.2009.94","article-title":"Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy","volume":"24","author":"Falavarjani","year":"2010","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2024.06.011_bib7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00417-010-1430-x","article-title":"Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage","volume":"248","author":"Nazari","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2024.06.011_bib8","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.3928\/15428877-20120517-03","article-title":"Successful management of choroidal metastasis with intravitreal ranibizumab injections","volume":"43","author":"Detorakis","year":"2012","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"3","key":"10.1016\/j.ophtha.2024.06.011_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5114\/ceji.2016.63132","article-title":"The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy","volume":"41","author":"Po\u017carowska","year":"2016","journal-title":"Cent Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.06.011_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40942-021-00343-3","article-title":"Future of anti-VEGF: biosimilars and biobetters","volume":"8","author":"Kapur","year":"2022","journal-title":"Int J Retina Vitreous"},{"issue":"2","key":"10.1016\/j.ophtha.2024.06.011_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000513048","article-title":"Brolucizumab: a newly developed anti-VEGF molecule for the treatment of neovascular age-related macular degeneration","volume":"244","author":"Tadayoni","year":"2021","journal-title":"Ophthalmologica"},{"issue":"5","key":"10.1016\/j.ophtha.2024.06.011_bib12","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41433-019-0670-1","article-title":"Faricimab: expanding horizon beyond VEGF","volume":"34","author":"Sharma","year":"2020","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.ophtha.2024.06.011_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/jop.2013.0206","article-title":"Safety monitoring of ophthalmic biologics: a systematic review of pre-and postmarketing safety data","volume":"30","author":"Penedones","year":"2014","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ophtha.2024.06.011_bib14","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1097\/IAE.0b013e3182278ab4","article-title":"A\u00a0systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections","volume":"31","author":"Van der Reis","year":"2011","journal-title":"Retina"},{"issue":"9142","key":"10.1016\/j.ophtha.2024.06.011_bib15","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S0140-6736(05)79825-1","article-title":"Reporting of safety data from randomised trials","volume":"352","author":"Ioannidis","year":"1998","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ophtha.2024.06.011_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00000658-200206000-00007","article-title":"Quality of complication reporting in the surgical literature","volume":"235","author":"Martin","year":"2002","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ophtha.2024.06.011_bib17","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ophtha.2020.11.011","article-title":"Risk of inflammation, retinal vasculitis, and retinal occlusion\u2013related events with brolucizumab: post hoc review of HAWK and HARRIER","volume":"128","author":"Mon\u00e9s","year":"2021","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2024.06.011_bib18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/s41433-020-01227-w","article-title":"Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world","volume":"35","author":"Sharma","year":"2021","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.ophtha.2024.06.011_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1080\/14712598.2020.1782379","article-title":"Abicipar pegol for neovascular age-related macular degeneration","volume":"20","author":"Hussain","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"10.1016\/j.ophtha.2024.06.011_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41433-019-0607-8","article-title":"Abicipar pegol: the non-monoclonal antibody anti-VEGF","volume":"34","author":"Sharma","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.ophtha.2024.06.011_bib21","article-title":"ASRS reports six cases of occlusive retinal vasculitis linked to pegcetacoplan injection","author":"Hutton","year":"2023","journal-title":"Ophthalmology Times"},{"key":"10.1016\/j.ophtha.2024.06.011_bib22","series-title":"(GA)","article-title":"SYFOVRE\u00ae (pegcetacoplan injection) continued to demonstrate increasing treatment effects over 30 months in patients with geographic atrophy","year":"2023"},{"key":"10.1016\/j.ophtha.2024.06.011_bib23","series-title":"ReST Committee Update on intraocular inflammation (IOI)","year":"2023"},{"issue":"11","key":"10.1016\/j.ophtha.2024.06.011_bib24","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1097\/IAE.0000000000003582","article-title":"Risk of intraocular inflammation after injection of antivascular endothelial growth factor agents: a meta-analysis","volume":"42","author":"Patil","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2024.06.011_bib25","series-title":"Delphi Process: A Methodology Used for the Elicitation of Opinions of Experts","author":"Brown","year":"1968"},{"issue":"8","key":"10.1016\/j.ophtha.2024.06.011_bib26","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/jamaophthalmol.2021.1078","article-title":"New classification for the reporting of complications in retinal detachment surgical trials","volume":"139","author":"Xu","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2024.06.011_bib27","first-page":"10","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Pract Assess Res Eval"},{"issue":"3","key":"10.1016\/j.ophtha.2024.06.011_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0020-7489(93)90033-Q","article-title":"The Delphi technique: a comparison of results obtained using two expert panels","volume":"30","author":"Duffield","year":"1993","journal-title":"Int J Nurs Stud"},{"issue":"3","key":"10.1016\/j.ophtha.2024.06.011_bib29","doi-asserted-by":"crossref","DOI":"10.3310\/hta2030","article-title":"Consensus development methods, and their use in clinical guideline development","volume":"2","author":"Murphy","year":"1998","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.ophtha.2024.06.011_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ecns.2016.02.001","article-title":"The prebriefing concept: a Delphi study of CHSE experts","volume":"12","author":"McDermott","year":"2016","journal-title":"Clin Simul Nurs"},{"issue":"5","key":"10.1016\/j.ophtha.2024.06.011_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrurol.2017.26","article-title":"Semantics in active surveillance for men with localized prostate cancer\u2014results of a modified Delphi consensus procedure","volume":"14","author":"Bruinsma","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"9","key":"10.1016\/j.ophtha.2024.06.011_bib32","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S1473-3099(22)00124-4","article-title":"Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India","volume":"22","author":"Muthu","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ophtha.2024.06.011_bib33","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00268-020-05476-4","article-title":"Defining major surgery: a Delphi consensus among European Surgical Association (ESA) members","volume":"44","author":"Martin","year":"2020","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.ophtha.2024.06.011_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ophtha.2024.06.011_bib35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ophtha.2024.06.011_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/SLA.0b013e3181afde41","article-title":"The accordion severity grading system of surgical complications","volume":"250","author":"Strasberg","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ophtha.2024.06.011_bib37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1245\/s10434-014-4141-4","article-title":"Development and assessment of Memorial Sloan Kettering Cancer Center\u2019s surgical secondary events grading system","volume":"22","author":"Strong","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ophtha.2024.06.011_bib38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2165\/00002018-200427080-00010","article-title":"Using MedDRA: implications for risk management","volume":"27","author":"Brown","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.ophtha.2024.06.011_bib39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ajo.2018.07.014","article-title":"Reporting harm in glaucoma surgical trials: systematic review and a consensus-derived new classification system","volume":"194","author":"Sii","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2024.06.011_bib40","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.oret.2022.02.007","article-title":"Recommendations for OCT angiography reporting in retinal vascular disease: a Delphi approach by international experts","volume":"6","author":"Munk","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"5","key":"10.1016\/j.ophtha.2024.06.011_bib41","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1177\/11206721211052852","article-title":"Recommendations for the management of diabetic macular oedema with intravitreal dexamethasone implant: a national Delphi consensus study","volume":"32","author":"Kodjikian","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"15","key":"10.1016\/j.ophtha.2024.06.011_bib42","first-page":"5131","article-title":"Complement inhibitors for advanced dry age-related macular degeneration (geographic atrophy): some light at the end of the tunnel?","volume":"12","author":"Cruz-Pimentel","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"9","key":"10.1016\/j.ophtha.2024.06.011_bib43","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.techfore.2011.05.006","article-title":"Desirability bias in foresight: consequences for decision quality based on Delphi results","volume":"78","author":"Ecken","year":"2011","journal-title":"Technol Forecast Soc Change"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202400366X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164202400366X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:24:12Z","timestamp":1736475852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164202400366X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S016164202400366X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.06.011","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2024.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}